Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

In this review, we summarise the current knowledge on the indications and contraindications
of transjugular intrahepatic portosystemic shunt (TIPS) placement for the treatment of the …

This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Acute-on-chronic liver failure (ACLF), which was described relatively recently (2013), is a
severe form of acutely decompensated cirrhosis characterised by the existence of organ …

Background: The efficacy of rifaximin in the secondary prevention of overt hepatic
encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode …

Background The survival benefit of early placement of transjugular intrahepatic
portosystemic shunts (TIPS) in patients with cirrhosis and acute variceal bleeding is …

Background & Aims The relationship between acute-on-chronic liver failure (ACLF) and
acute variceal bleeding (AVB) is poorly understood. Specifically, the prevalence and …

Background & Aims Compared with drugs plus endoscopy, placement of transjugular
portosystemic shunt within 72 hours of admission to the hospital (early or preventive …

Conclusions In patients with Child‐Pugh B cirrhosis and AVB, risk stratification using CLIF‐C
ADs identifies a subgroup with high risk of death that may derive survival benefit from early …